Lv5
1150 积分 2023-12-04 加入
SOHO State of the Art Updates and Next Questions | Will CAR-T Replace ASCT in NDMM?
9天前
已完结
Health-Related Quality of Life in Patients With Relapsed/Refractory Multiple Myeloma Treated With Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone: An Analysis of Patient-Reported Outcomes From the Phase 3 CANDOR Trial
9天前
已完结
Mitigating Fear and Loathing in Managing Acute Myeloid Leukemia
17天前
已完结
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
2个月前
已完结
New classifications of B-cell neoplasms: a comparison of 5th WHO and International Consensus classifications
2个月前
已完结
Association of thrombocytopenia with disease burden, high-risk cytogenetics, and survival in newly diagnosed multiple myeloma patients treated with novel therapies
2个月前
已完结
Multiparametric Flow Cytometry in the Evaluation of Plasma Cell Proliferative Disorders: Current Paradigms for Clinical Practice
2个月前
已完结
Smoldering Multiple Myeloma
2个月前
已关闭
High‐risk multiple myeloma: Redefining genetic, clinical, and functional high‐risk disease in the era of molecular medicine and immunotherapy
2个月前
已完结
Risk-adapted treatment for multiple myeloma: assessing the current potential and a roadmap for the future
2个月前
已完结
Construction of a bifunctional BiVO4 based S-scheme heterojunction for enhancing photothermal-photocatalytic oxygen generation and benzaldehyde production
6个月前
已采纳
Efficacy and tolerability of adjuvant perampanel: an Australian multicenter real-world observational study in refractory focal and generalized epilepsy syndromes
6个月前
已采纳
皖公网安备34019202002308
